BABA vs TCRX · P/E 20, rev $148.40B vs rev $2.0M
Alibaba Group Holding Ltd (BABA) versus Tscan Therapeutics Inc (TCRX) — a side-by-side from cached financials, not a winner call.
Alibaba Group Holding Ltd (BABA) is a internet retail company listed on US.
Tscan Therapeutics Inc (TCRX) is a biotechnology company listed on NASDAQ.
Latest reported BABA revenue for 2026-03-31 was $148.40B. Net income was $15.02B. Revenue was up 8.1% from 2025-03-31 to 2026-03-31. BABA currently screens at market cap $305.19B and trailing P/E 19.6.
Latest reported TCRX revenue for 2026-06-30 was $2.0M. Net income was -$59.0M. TCRX currently screens at market cap $62.1M.
BABA currently screens at market cap $305.19B and trailing P/E 19.6. TCRX currently screens at market cap $62.1M.
Not investment advice. Open the BABA and TCRX stock pages for the full models.
Not investment advice.